Table 1. Baseline patient characteristics (n=71).
| Variable | No. of patients (%) |
|---|---|
| Total | 71 |
| Median age (range); years | 64.5 (39–81) |
| Gender | |
| Male | 39 (55) |
| Female | 32 (45) |
| ECOG PS | |
| 0 | 67 (94) |
| 1 | 4 (6) |
| Histologic grade | |
| Poorly differentiated | 15 (21) |
| Well, moderately differentiated | 56 (79) |
| Tumour stage | |
| T1-T2 | 10 (14.1) |
| T3-T4 | 61 (85.9) |
| Lymph node metastasis | |
| Yes | 48 (68) |
| None | 23 (32) |
| Adjuvant treatment | |
| Radiochemotherapy | 30 (42) |
| Gemcitabine monotherapy | 12 (17) |
| Tumour recurrence | |
| Local | 11 (15.5) |
| Distant | 33 (46.5) |
| Local and distant | 13 (18.3) |
ECOG PS=Eastern Cooperative Oncology Group performance status.